---
title: "AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295669971.md"
description: "CEO Thomas K. Equels has urged for a proactive assessment of wide-ranging antiviral defenses before the emergence of new viral dangers. Equels emphasizes the need for preparedness in the face of potential threats."
datetime: "2026-08-12T12:46:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295669971.md)
  - [en](https://longbridge.com/en/news/295669971.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295669971.md)
generator: "portal-rs"
---

# AIM ImmunoTech CEO Highlights Biodefense and Military Force Protection in Newly Published ‘Breaking Defense’ Article

CEO Thomas K. Equels has urged for a proactive assessment of wide-ranging antiviral defenses before the emergence of new viral dangers. Equels emphasizes the need for preparedness in the face of potential threats.

### Related Stocks

- [AIM.US](https://longbridge.com/en/quote/AIM.US.md)
- [AIMID.US](https://longbridge.com/en/quote/AIMID.US.md)
- [AIMI.US](https://longbridge.com/en/quote/AIMI.US.md)

## Related News & Research

- [Why Now On-Demand Conference Spotlights Nine Emerging Biotech And Healthcare Stories](https://longbridge.com/en/news/297400450.md)
- [SalMar – Record-strong biological performance](https://longbridge.com/en/news/296859687.md)
- [Gap surges as analysts see Old Navy recovery, new CEO as catalysts](https://longbridge.com/en/news/297334293.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [BARRA: Net loss halved and biological risks reduced, but revenue declined amid ongoing strategic transformation](https://longbridge.com/en/news/297340993.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**